journal article Open Access Mar 29, 2006

Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study

View at Publisher Save 10.1093/humrep/del085
Topics

No keywords indexed for this article. Browse by subject →

References
20
[1]
Abdel "Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease" Clin Endocrinol (Oxf) (1990) 10.1111/j.1365-2265.1990.tb03896.x
[2]
Balasch "The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone" Hum Reprod (1995) 10.1093/oxfordjournals.humrep.a136154
[3]
Callahan "The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence" N Engl J Med (1994) 10.1056/nejm199407283310407
[4]
Coelingh "Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group" Fertil Steril (1998) 10.1016/s0015-0282(97)00423-8
[5]
The ESHRE Capri Workshop Group "Multiple gestation pregnancy" The ESHRE Capri Workshop Group Hum Reprod (2000)
[6]
Golan "Ovarian hyperstimulation syndrome: an update review" Obstet Gynecol Surv (1989) 10.1097/00006254-198906000-00004
[7]
Homburg "Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements" Hum Reprod Update (1999) 10.1093/humupd/5.5.493
[8]
Homburg "Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome" BMJ (1988) 10.1136/bmj.297.6655.1024
[9]
Larsen "Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome" Fertil Steril (1990) 10.1016/s0015-0282(16)53335-4
[10]
Loumaye "Clinical assessment of human gonadotrophins produced by recombinant DNA technology" Hum Reprod (1996) 10.1093/humrep/11.suppl_5.95
[11]
Loumaye "Clinical evidence for an LH ‘ceiling’ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation" Hum Reprod (2003) 10.1093/humrep/deg066
[12]
McFaul "Treatment of clomiphene citrate–resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin" Fertil Steril (1990) 10.1016/s0015-0282(16)53511-0
[13]
Nugent "Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome" Cochrane Database Syst Rev (2000)
[14]
Sagle "A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome" Fertil Steril (1991) 10.1016/s0015-0282(16)54059-x
[15]
Seibel "Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin" Fertil Steril (1985) 10.1016/s0015-0282(16)48551-1
[16]
Shoham "Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients" Fertil Steril (1991) 10.1016/s0015-0282(16)54715-3
[17]
Shoham "Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism" Fertil Steril (1993) 10.1016/s0015-0282(16)55852-x
[18]
Wolfenson "Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations" Reprod Biomed Online (2005) 10.1016/s1472-6483(10)60819-x
[19]
Yarali "Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study" Fertil Steril (1999) 10.1016/s0015-0282(99)00209-5
[20]
Yarali "Gonadotrophin treatment in patients with polycystic ovary syndrome" Reprod Biomed Online (2004) 10.1016/s1472-6483(10)61099-1
Metrics
70
Citations
20
References
Details
Published
Mar 29, 2006
Vol/Issue
21(7)
Pages
1798-1804
Cite This Article
Peter Platteau, Anders Nyboe Andersen, Adam Balen, et al. (2006). Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Human Reproduction, 21(7), 1798-1804. https://doi.org/10.1093/humrep/del085